Murine Xenograft Model for Human Uterine Fibroids: An In Vivo Imaging Approach

Reproductive Sciences

Volumn 16, Issue 9, 2009, Pages 827-842

  Suo, Guangli ^a   Sadarangani, Anil ^a   Lamarca, Babbette ^b   Cowan, Bryan ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

estradiol releasing pellets; GFP; Leiomyoma; lentivirus; luciferase

Indexed keywords

DNA BINDING PROTEIN; GREEN FLUORESCENT PROTEIN; LUCIFERASE; RAG2 PROTEIN, MOUSE;

ANIMAL; ARTICLE; CANCER TRANSPLANTATION; CELL CULTURE; CYTOLOGY; DISEASE MODEL; FEMALE; GENETIC TRANSFECTION; GENETICS; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; LEIOMYOMA; LENTIVIRINAE; METHODOLOGY; MOUSE; MOUSE MUTANT; PATHOLOGY; SMOOTH MUSCLE FIBER; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSPLANTATION; UTERUS CANCER; XENOGRAFT;

ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; FEMALE; GREEN FLUORESCENT PROTEINS; HUMANS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; KIDNEY; LEIOMYOMA; LENTIVIRUS; LUCIFERASES; MICE; MICE, KNOCKOUT; MYOCYTES, SMOOTH MUSCLE; NEOPLASM TRANSPLANTATION; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; UTERINE NEOPLASMS;

EID: 70350745326     PISSN: 19337191     EISSN: None     Source Type: Journal    
DOI: 10.1177/1933719109336615     Document Type: Article

References (34)

1. Cramer S.F., Patel A. The nonrandom regional distribution of uterine leiomyomas: a clue to histogenesis ? Hum Pathol. 1992; 23 (6): 635 - 638.
2. Olive D.L. Analysis of clinical fertility trials: a methodologic review. Fertil Steril. 1986; 45 (2): 157 - 171.
3. Morales A.J., Kettel L.M. Quality of life assessment. Semin Reprod Endocrinol. 1996; 14 (2): 155 - 159.
4. Dembek C.J., Pelletier E.M., Isaacson K.B., Spies J.B. Payer costs in patients undergoing uterine artery embolization, hysterectomy, or myomectomy for treatment of uterine fibroids. J Vasc Interv Radiol. 2007; 18 (10): 1207 - 1213.
5. Hartmann K.E., Birnbaum H., Ben-Hamadi R., et al. Annual costs associated with diagnosis of uterine leiomyomata. Obstet Gynecol. 2006; 108 (4): 930 - 937.
6. Linder D., Gartler S.M. Glucose-6-phosphate dehydrogenase mosaicism: utilization as a cell marker in the study of leiomyomas. Science. 1965; 150 (692): 67 - 69.
7. Wilson E.A., Yang F., Rees E.D. Estradiol and progesterone binding in uterine leiomyomata and in normal uterine tissues. Obstet Gynecol. 1980; 55 (1): 20 - 24.
8. Rein M.S., Barbieri R.L., Friedman A.J. Progesterone: a critical role in the pathogenesis of uterine myomas. Am J Obstet Gynecol. 1995; 172 (1 pt 1): 14 - 18.
9. Andersen J., DyReyes V.M., Barbieri R.L., Coachman D.M., Miksicek R.J. Leiomyoma primary cultures have elevated transcriptional response to estrogen compared with autologous myometrial cultures. J Soc Gynecol Investig. 1995; 2 (3): 542 - 551.
10. Ichimura T., Kawamura N., Ito F., et al. Correlation between the growth of uterine leiomyomata and estrogen and progesterone receptor content in needle biopsy specimens. Fertil Steril. 1998; 70 (5): 967 - 971.
11. Vu K., Greenspan D.L., Wu T.C., Zacur H.A., Kurman R.J. Cellular proliferation, estrogen receptor, progesterone receptor, and bcl-2 expression in GnRH agonist-treated uterine leiomyomas. Hum Pathol. 1998; 29 (4): 359 - 363.
12. Mashal R.D., Fejzo M.L., Friedman A.J., et al. Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenetic aberrations in the development of leiomyomata. Genes Chromosomes Cancer. 1994; 11 (1): 1 - 6.
13. Wang T., Zhang X., Obijuru L., et al. A micro-RNA signature associated with race, tumor size, and target gene activity in human uterine leiomyomas. Genes Chromosomes Cancer. 2007; 46 (4): 336 - 347.
14. Vanharanta S., Pollard P.J., Lehtonen H.J., et al. Distinct expression profile in fumarate-hydratase-deficient uterine fibroids. Hum Mol Genet. 2006; 15 (1): 97 - 103.
15. Ingraham S.E., Lynch R.A., Surti U., et al. Identification and characterization of novel human transcripts embedded within HMGA2 in t(12;14)(q15;q241) uterine leiomyoma. Mutat Res. 2006; 602 (1-2): 43 - 53.
16. Everitt J.I., Wolf D.C., Howe S.R., Goldsworthy T.L., Walker C. Rodent model of reproductive tract leiomyomata. Clinical and pathological features. Am J Pathol. 1995; 146 (6): 1556 - 1567.
17. Yeung R.S., Xiao G.H., Jin F., Lee W.C., Testa J.R., Knudson A.G. Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene. Proc Natl Acad Sci U S A. 1994; 91 (24): 11413 - 11416.
18. Howe S.R., Gottardis M.M., Everitt J.I., Goldsworthy T.L., Wolf D.C., Walker C. Rodent model of reproductive tract leiomyomata. Establishment and characterization of tumor-derived cell lines. Am J Pathol. 1995; 146 (6): 1568 - 1579.
19. Wei J., Chiriboga L., Mizuguchi M., Yee H., Mittal K. Expression profile of tuberin and some potential tumorigenic factors in 60 patients with uterine leiomyomata. Mod Pathol. 2005; 18 (2): 179 - 188.
20. Hassan M.H., Eyzaguirre E., Arafa H.M., Hamada F.M., Salama S.A., Al-Hendy A. Memy I: a novel murine model for uterine leiomyoma using adenovirus-enhanced human fibroid explants in severe combined immune deficiency mice. Am J Obstet Gynecol. 2008; 199 (2): 156e1 - 156e8.
21. Legrand N., Weijer K., Spits H. Experimental model for the study of the human immune system: production and monitoring of ‘‘human immune system’’ Rag2-/-gamma c-/- mice. Methods Mol Biol. 2008; 415: 65 - 82.
22. Rice B.W., Cable M.D., Nelson M.B. In vivo imaging of light-emitting probes. J Biomed Opt. 2001; 6 (4): 432 - 440.
23. Kuo C., Coquoz O., Troy T.L., Xu H., Rice B.W. Three-dimensional reconstruction of in vivo bioluminescent sources based on multispectral imaging. J Biomed Opt. 2007; 12 (2): 024007.
24. Shinkai Y., Rathbun G., Lam K.P., et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell. 1992 ; 68 (5): 855 - 867.
25. Soudais C., Shiho T., Sharara L.I., et al. Stable and functional lymphoid reconstitution of common cytokine receptor gamma chain deficient mice by retroviral-mediated gene transfer. Blood. 2000; 95 (10): 3071 - 3077.
26. Baenziger S., Tussiwand R., Schlaepfer E., et al. Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2-/-gamma c-/- mice. Proc Natl Acad Sci U S A. 2006 ; 103 (43): 15951 - 15956.
27. Traggiai E., Chicha L., Mazzucchelli L., et al. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science. 2004; 304 (5667): 104 - 107.
28. D’Hallewin M.A., El Khatib S., Leroux A., Bezdetnaya L., Guillemin F. Endoscopic confocal fluorescence microscopy of normal and tumor bearing rat bladder. J Urol. 2005; 174 (2): 736 - 740.
29. Tanaka M., Gee J.R., De L.A. Cerda J., et al. Noninvasive detection of bladder cancer in an orthotopic murine model with green fluorescence protein cytology. J Urol. 2003; 170 (3): 975 - 978.
30. Bukowski E.J., Bright F.V. Minimizing urine autofluorescence under multi-photon excitation conditions. Appl Spectrosc. 2004 ; 58 (9): 1101 - 1105.
31. Guarnaccia M.M., Rein M.S. Traditional surgical approaches to uterine fibroids: abdominal myomectomy and hysterectomy. Clin Obstet Gynecol. 2001; 44 (2): 385 - 400.
32. Yeh J., Rein M., Nowak R. Presence of messenger ribonucleic acid for epidermal growth factor (EGF) and EGF receptor demonstrable in monolayer cell cultures of myometria and leiomyomata. Fertil Steril. 1991; 56 (5): 997 - 1000.
33. Giudice L.C., Irwin J.C., Dsupin B.A., et al. Insulin-like growth factor (IGF), IGF binding protein (IGFBP), and IGF receptor gene expression and IGFBP synthesis in human uterine leiomyomata. Hum Reprod. 1993; 8 (11): 1796 - 1806.
34. Lethaby A.E., Vollenhoven B.J. An evidence-based approach to hormonal therapies for premenopausal women with fibroids. Best Pract Res Clin Obstet Gynaecol. 2008; 22 (2): 307 - 331.